Aryeh Jason — SEC insider filings

SEC reporting owner CIK 1376960. 33 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 33 filings on record, filed 2021-06-07 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
LIGAND PHARMACEUTICALS INC (LGND)Director14—18 legs · 20,393 sh · $4,684,62419
Orchestra BioMed Holdings, Inc. (OBIO)Director133 legs · 10,636 sh · $39,931—17
Anebulo Pharmaceuticals, Inc. (ANEB)Director3——5
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Director3——3

Insider filings — Aryeh Jason

FiledFormIssuerReported transactionsSource
2026-11-124LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 500 @ $319.99 · Sale (S): 844 @ $320.00 · Sale (S): 646 @ $320 · Sale (S): 10 @ $320.02 · Sale (S): 500 @ $320.10 · Sale (S): 500 @ $320.20EDGAR
2026-11-064LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 282 @ $319.99EDGAR
2026-11-034LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 50 @ $317.74 · Sale (S): 50 @ $318.23 · Sale (S): 52 @ $320.24 · Sale (S): 1,209 @ $320.42 · Sale (S): 50 @ $320.49 · Sale (S): 700 @ $320.43EDGAR
2026-06-254Orchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 42,553 (derivative) @ $0EDGAR
2026-06-124LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 836 @ $0 · Sale (S): 500 @ $250 · Sale (S): 4,500 @ $250 · Grant/award (A): 2,938 (derivative) @ $0EDGAR
2026-06-054LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Grant/award (A): 25,907EDGAR
2026-05-204Orchestra BioMed Holdings, Inc. (OBIO)Purchase (P): 665 @ $3.75EDGAR
2026-05-194Orchestra BioMed Holdings, Inc. (OBIO)Purchase (P): 8,971 @ $3.90EDGAR
2025-12-084LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,034 @ $69.51 · Option exercise (M): 2,034 (derivative) @ $0EDGAR
2025-09-244LIGAND PHARMACEUTICALS INC (LGND)Sale (S): 4,418 @ $170.41 · Sale (S): 4,628 @ $170.96 · Sale (S): 954 @ $171.92EDGAR
2025-09-194Orchestra BioMed Holdings, Inc. (OBIO)Purchase (P): 1,000 @ $2.45EDGAR
2025-08-084Orchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 15,000 @ $0EDGAR
2025-07-174LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Grant/award (A): 19,506EDGAR
2025-06-274Orchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 12,422 @ $0 · Grant/award (A): 36,797 (derivative) @ $0EDGAR
2025-06-104LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,209 @ $0 · Grant/award (A): 5,783 (derivative) @ $0EDGAR
2025-04-074Anebulo Pharmaceuticals, Inc. (ANEB)Grant/award (A): 25,000 (derivative) @ $0 · Grant/award (A): 4,964 (derivative) @ $0EDGAR
2024-12-304Orchestra BioMed Holdings, Inc. (OBIO)Option exercise (M): 11,700 @ $4.30 · Option exercise (M): 11,700 (derivative) @ $0EDGAR
2024-08-214LIFECORE BIOMEDICAL, INC. \DE\ (LFCR)Grant/award (A): 24,554EDGAR
2024-06-214Orchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 5,376 @ $0 · Grant/award (A): 17,068 (derivative) @ $0EDGAR
2024-06-184LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,252 @ $0 · Grant/award (A): 5,444 (derivative) @ $0EDGAR
2024-06-174Anebulo Pharmaceuticals, Inc. (ANEB)Grant/award (A): 41,667 (derivative) @ $0 · Grant/award (A): 2,482 (derivative) @ $0EDGAR
2024-05-024LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,406 @ $52.30 · Option exercise (M): 2,406 (derivative) @ $0EDGAR
2024-03-064LIGAND PHARMACEUTICALS INC (LGND)Option exercise (M): 2,893 @ $39.35 · Option exercise (M): 2,893 (derivative) @ $0EDGAR
2023-07-244Orchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 25,000 (derivative) @ $0EDGAR
2023-06-134LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,142 @ $0 · Grant/award (A): 5,461 (derivative) @ $0EDGAR
2023-05-194/AOrchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 23,250 (derivative)EDGAR
2023-05-054/AOrchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 22,492 (derivative)EDGAR
2023-05-054Orchestra BioMed Holdings, Inc. (OBIO)Option exercise (M): 11,246 · Option exercise (M): 11,246 (derivative)EDGAR
2023-01-304Orchestra BioMed Holdings, Inc. (OBIO)Grant/award (A): 51,738 · Grant/award (A): 18,600 (derivative) · Grant/award (A): 6,975 (derivative) · Grant/award (A): 23,250 (derivative)EDGAR
2022-12-274LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 4,484 (derivative) @ $0EDGAR
2022-10-034Anebulo Pharmaceuticals, Inc. (ANEB)Grant/award (A): 30,425 (derivative) @ $0EDGAR
2022-06-134LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 1,004 @ $0 · Grant/award (A): 4,340 (derivative) @ $0EDGAR
2021-06-074LIGAND PHARMACEUTICALS INC (LGND)Grant/award (A): 630 @ $0 · Grant/award (A): 3,269 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1376960 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs